1,425 pharmaceutical and medication recalls tracked. Stay informed about FDA drug safety alerts, prescription medications, over-the-counter drugs, and dietary supplements.
Looking for a specific drug? Use the search page to find recalls by medication name, manufacturer, or NDC number.
Medline Industries recalled 1,928 medical procedure kits due to a safety hazard involving butyrate tubing. The recall affects multiple kit models containing MASTISOL liquid adhesive. The defective tubing may crack during use, posing a risk to patients and healthcare providers.
Medline recalled multiple medical procedure convenience kits on December 12, 2025. The recall affects 66 units containing MASTISOL liquid adhesive. The adhesive's tubing may crack, posing a serious risk during use.
Medline Industries recalled select medical procedure convenience kits on December 12, 2025. The recall affects 40 units due to risks associated with MASTISOL liquid adhesive. The adhesive's tubing may crack during use, posing safety concerns.
NIPRO Technical Services recalled 499 units of Conductivity Standard Solutions on December 12, 2025. A defect affects the conductivity values, leading to incorrect readings for dialysate. Patients and healthcare providers must stop using the product immediately.
Medline Industries, LP recalled 1,928 circumcision procedure kits on December 12, 2025. The kits contain MASTISOL liquid adhesive, which may crack during use. Healthcare providers and patients must stop using these kits immediately.
Medline Industries, LP recalled 1,928 medical procedure convenience kits on December 12, 2025. The kits contain MASTISOL liquid adhesive linked to cracking tubing during use. Healthcare providers and patients must stop using these kits immediately.
Medline Industries recalled 236 medical procedure kits on December 12, 2025. The kits contain MASTISOL liquid adhesive that may cause butyrate tubing to crack. Patients and healthcare providers should stop using these kits immediately.
Medline Industries recalled 1,928 medical procedure convenience kits on December 12, 2025, due to a risk of crack in the adhesive tubing. The kits contain MASTISOL liquid adhesive, leading to safety concerns. Healthcare providers and patients should stop using the kits immediately and follow the recall instructions.
Medline Industries, LP recalled 857 medical procedure convenience kits on December 12, 2025. The kits contain MASTISOL liquid adhesive which can cause butyrate tubing to crack during use. Healthcare providers and patients must stop using these kits immediately.
Medline Industries recalled 456 medical procedure kits on December 12, 2025, due to a potential hazard involving MASTISOL liquid adhesive. The defective butyrate tubing may crack during use, posing a risk to patients and healthcare providers. Consumers must stop using these kits immediately and seek further instructions.
Elekta recalled the Leksell GammaPlan RT Treatment Planning System on December 12, 2025, due to a software error. This defect may lead to incorrect patient irradiation if not detected. Healthcare providers must stop using the software immediately.
Elekta recalled the Leksell GammaPlan Radionuclide RT Treatment Planning System on December 12, 2025. The software, used for treatment planning, may incorrectly irradiate patient locations due to a stereotactic reference error. This recall affects users worldwide, including in the U.S. and various international locations.
Bard Peripheral Vascular Inc. recalled 14,935 units of the Broviac 4.2 Fr Single-Lumen CV Catheter Tray on December 12, 2025. Damage to the outer tray may compromise the sterile barrier, posing a high hazard. Healthcare providers and patients should stop using the device immediately.
Applied Medical Resources recalled 450 units of the Kii Low Profile, Bladed Dual Pack on December 11, 2025, due to a potential safety issue. The blade obturator may extend beyond safe limits after assembly, posing a risk to patients. Healthcare providers and patients should stop using the device immediately.
Instrumentation Laboratory recalled 7,720 coagulation testing devices on December 11, 2025. The recall stems from a potential for microbial contamination. Healthcare providers and patients should stop using the device immediately.
Fujirebio Diagnostics recalled 179 units of Lumipulse ¿-Amyloid Plasma Controls on December 11, 2025. The recall stems from inaccurate test results leading to potential misclassification of Alzheimer's disease. Customers should stop using the device immediately and follow the manufacturer's instructions.
Fujirebio Diagnostics recalled 1,423 units of Lumipulse G ¿-Amyloid 1-42-N Plasma Immunoreaction Cartridges on December 11, 2025. The recall affects models found to provide inaccurate test results, potentially misclassifying Alzheimer's disease. Healthcare providers and patients should stop using these cartridges immediately.
Fujirebio Diagnostics recalled 23 units of its Lumipulse G pTau217/B-Amyloid 1-42 Plasma Ratio test on December 11, 2025. The recall follows concerns that the product may produce inaccurate test results, potentially misclassifying patients with Alzheimer's disease. Healthcare providers should stop using this device immediately and follow recall instructions.
Fujirebio Diagnostics recalled 128 units of Lumipulse G ¿-Amyloid 1-42-N Plasma Calibrators on December 11, 2025. The recall stems from the risk of inaccurate test results leading to misclassification of Alzheimer’s disease. Affected products may cause patients to receive unnecessary additional clinical testing.
Fujirebio Diagnostics recalled 1,569 units of Lumipulse G pTau 217 Plasma Immunoreaction Cartridges on December 11, 2025. The recall affects users due to potential inaccurate test results associated with Alzheimer's disease classifications. Customers in 13 states should stop using the product immediately.
Fujirebio Diagnostics recalled 148 units of Lumipulse pTau 217 Plasma Controls on December 11, 2025. The recall follows reports of inaccurate test results that misclassify patients regarding Alzheimer’s disease. The affected product may falsely elevate positive or indeterminate results, increasing the risk of incorrect patient classification.
Fujirebio Diagnostics has recalled 117 units of Lumipulse G pTau 217 Plasma Calibrators due to inaccurate test results. The recall was announced on December 11, 2025, after customers reported false classifications of Alzheimer’s disease. Affected products were distributed nationwide, including in states like California and Florida.
GE HealthCare recalled 38 Nuclear Medicine systems on December 10, 2025, due to potential detector falls. The affected systems may have been relocated without adequate support, risking serious injury. No incidents have been reported, but the recall is classified as a Class II hazard.
GE HealthCare recalled three Nuclear Medicine systems on December 10, 2025. The recall follows concerns over inadequate detector support, which could lead to a fall and serious injury. No incidents have been reported to date.
Receive immediate notifications when medications you care about are recalled. Stay safe with timely FDA drug safety alerts.